Icon

OPTIMARK (nda020937)- (1654.5MG/5ML (330.9MG/ML),3309MG/10ML (330.9MG/ML),4963.5MG/15ML (330.9MG/ML),6618MG/20ML (330.9MG/ML))

GADOVERSETAMIDE LIEBEL-FLARSHEIM
1654.5MG/5ML (330.9MG/ML),3309MG/10ML (330.9MG/ML),4963.5MG/15ML (330.9MG/ML),6618MG/20ML (330.9MG/ML)
No No
2009-Jul-14 Expired
None None
None No
Optimark is a gadolinium-based paramagnetic contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use: • In patients with abnormal blood-brain barrier or abnormal vascularity of the brain, spine and associated tissues. • To provide contrast enhancement and facilitate visualization of lesions with abnormal vascularity in the liver in patients who are highly suspect for liver structural abnormalities on computed tomography.
0 0 0
Total Other Developers None
Drugs with Suitability No
1654.5MG/5ML (330.9MG/ML) ** ** - - -
3309MG/10ML (330.9MG/ML) ** ** - - -
4963.5MG/15ML (330.9MG/ML) ** ** - - -
6618MG/20ML (330.9MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.